about
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat modelCoexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combinationHCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor.The antineoplastic role of bisphosphonates: from basic research to clinical evidence.Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphomaHepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.The role of ribavirin in the combination therapy of hepatitis C virus infection.Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs.Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology.Treatment of cryptosporidiosis in immunocompromised hosts.Retroperitoneal fibrosis and ankylosing spondylitis: which links?Diabetes in chronic liver disease: from old concepts to new evidence.Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography.Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD).Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease.The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients.The Liver as Another Possible Target Organ for Bacillus cereus Infection.An unusual post-traumatic case of extrahepatic bile duct compression.Proton pump inhibitor prescription abuse and sepsis in cirrhosis.Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept studyLiver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience.Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age.Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge.Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study.Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection.Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age.Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis: response to Lecube et al.Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype.Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient.Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy.Intravenous infusion of diarginylinsulin, an insulin analogue: effects on glucose turnover and lipid levels in insulin-treated type II diabetic patients.S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury.Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications.Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support.Chemotherapy-induced steatohepatitis in colorectal cancer patients.
P50
Q30360538-30A64C90-4F80-4A49-9B4F-A5A6C92E8AF7Q33310216-787611F2-A6A6-4A69-82AF-4E600112015DQ33651263-B64E46D4-EDED-438C-AD7A-5E16539B9FEDQ34479825-13EED502-DABD-4402-9C49-5F8F7A13266FQ34774141-5C4D7374-DB77-41D9-9A49-57315594E0EDQ35540836-9CDA7BA6-01C1-4333-A480-BC0CE5BB7AC5Q35575660-A452E14A-EB38-40CB-90F7-F8702434A4D8Q35783876-66C75AFB-260E-49EC-8491-950D4134FF45Q35848031-FE398EE3-4433-4C46-AE73-F2CD6789F70DQ36026145-2D20DEB2-DC2D-4DD3-9A68-DB4DB676DEEBQ36028043-FD93DBA9-AD1D-4C66-9F68-A7EBD190C627Q36188559-BD7182E4-B126-4A11-BE3F-0F0CB301B2C5Q36220308-AA5735AF-8B4A-429A-96CC-097216EFA5C5Q36408704-B5E96A87-988E-4DA9-ACF4-7DF7F74F6453Q37180152-84FF8303-E5C5-4891-B004-DF97A288D467Q38272004-983B1837-C223-43B4-8035-A98B36F4A496Q39774615-FEC3A250-8CA5-437A-847D-776B22F62932Q39790741-95BF943C-C3A8-43AF-8C4C-657D9BAEB914Q40394554-F7B771FD-795F-4716-9016-3929E7D4DB27Q40458291-98FA3EED-9C8F-4031-95E5-CA5DFEFAA71EQ40800407-74F22409-C939-4607-B7DC-F1FA919098B4Q41015330-AB2F9677-F5F6-4C42-8539-6A8364C10330Q41641046-569B84B5-7458-4662-8899-C8B259002DD0Q42210829-F9B906BE-6E84-4D2E-8037-BD145A4652F4Q42740878-467BA7BA-DA8F-41A4-8F97-B7407F5C8257Q42980735-697662DB-2F59-41DF-B8A8-517D8C3A4553Q42982920-E32BBE3C-3C4B-42F4-9DE9-C2B95F5141BBQ42997703-CEEFCE60-5F61-4428-8742-43E7A3115FA9Q43000221-1F7FD25F-EEC0-41C6-A950-BE5F95EDAC00Q43040458-D03BCBE6-5753-4B17-B14B-7197702A23B1Q43674589-28A9F31D-0A13-47E0-B233-E9E117B280BEQ43707694-7B1A1910-227B-426A-9A44-B7BCFFC2D53AQ44134966-03599E3B-1702-4A7E-B87A-76C115B89DD3Q44365805-BD84BB3D-B0A6-4C63-A13A-F73631F75399Q44378480-47E9140E-FE3D-4D13-90A0-68F41DCEF0B3Q44620739-E18D3DCB-05DE-42ED-96E2-529F2A4A4C1AQ44775434-5AA254FA-A8CE-44B8-A6BA-3475DCA999B4Q44903159-C2267E0B-5544-40D2-9716-9080BDAA5D1BQ44989766-24A8DC3C-5C12-458E-B2E4-0E6BC198917EQ45061234-2C2E1B27-0EA7-4746-8604-E0B36C56582D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Picardi
@ast
Antonio Picardi
@en
Antonio Picardi
@es
Antonio Picardi
@nl
type
label
Antonio Picardi
@ast
Antonio Picardi
@en
Antonio Picardi
@es
Antonio Picardi
@nl
prefLabel
Antonio Picardi
@ast
Antonio Picardi
@en
Antonio Picardi
@es
Antonio Picardi
@nl
P1053
C-2337-2012
P106
P1153
7005476713
P21
P31
P3829
P496
0000-0002-0230-218X